Itochu signs AI alliance while Itochu stock trades below EUR 12.31

Published on 10/07/2026 at 10:47 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

MOLCURE alliance targets AI drug discovery support on October 7, 2026. Itochu stock costs EUR 12.24 versus EUR 12.31, a 0.57 percent decline.

Itochu, JP3143600009, Illustration mit AI erstellt.

Itochu stock (ISIN JP3143600009) was trading at EUR 12.24 at Lang & Schwarz on October 7, 2026 at 10:39 a.m. CEST, down 0.57 percent versus the prior close of EUR 12.31. On the same date, ITOCHU Corporation announced a capital alliance with MOLCURE to strengthen support for AI-driven drug discovery.

AI alliance expands healthcare strategy

The October 7, 2026 agreement combines MOLCURE's technologies for antibody and peptide discovery with Itochu's pharmaceutical development support and international business network, according to ITOCHU Corporation. The planned support system is designed to cover the path from AI-assisted candidate creation through preclinical and clinical development, extending Itochu's healthcare platform rather than adding a standalone software product.

MOLCURE has developed an AI-driven discovery platform using a proprietary large language model, physical simulation technologies and experimental data, while Itochu's healthcare activities are centered primarily on its wholly owned A2 Healthcare subsidiary. The combination gives the trading group a concrete link between technology investment and pharmaceutical development services.

FY2026 figures set the baseline

For the year ended March 31, 2026, ITOCHU Corporation reported consolidated net profit of JPY 900.3 billion, core operating cash flows of JPY 940 billion and total assets of JPY 16.7 trillion, according to the company's investor relations page. The same page reports return on equity of 15 percent for that period, giving the new healthcare initiative a financial backdrop based on scale and cash generation.

The next scheduled reporting point is November 4, 2026, when Itochu plans to announce results for fiscal 2026 second quarter at 1:00 p.m. Japan Standard Time, as stated on the company's investor relations page. That date will provide the next quantified test of performance after the full-year figures for the year ended March 31, 2026.

Stock trades below prior close

The Lang & Schwarz quote stood at EUR 12.24 on October 7, 2026 at 10:39 a.m. CEST, compared with a prior close of EUR 12.31, a difference of minus EUR 0.07. The Tokyo Stock Exchange quote was last at JPY 2,161.50 on October 7, 2026 at 3:30 p.m. JST, while the 52-week range was JPY 1,653.60 to JPY 2,399.00 and market capitalization was JPY 15.1 trillion.

The further course of trading is shown by the continuously updated real-time quote of Itochu stock.